Validation of a liquid biopsy assay with molecular and clinical profiling of circulating tumor DNA
2021 · npj Precision Oncology · 65 citations
https://doi.org/10.1038/s41698-021-00202-2
C
Christine Lo
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
37
Papers
807
Citations
8
h-index
6
i10-index
Christine Lo is an academic researcher from Tempus Labs (United States). The author has contributed to research in topics: Cancer Genomics and Diagnostics & Genetic factors in colorectal cancer & Colorectal Cancer Treatments and Studies. The author has an h-index of 8, co-authored 32 publications.
ORCID: 0000-0003-0969-9973Papers by this author
worksOn the design of clone-based haplotyping
2013 · Genome Biology · 18 citations
https://doi.org/10.1186/gb-2013-14-9-r100
A Tumor-Naïve ctDNA Assay Detects Minimal Residual Disease in Resected Stage II or III Colorectal Cancer and Predicts Recurrence: Subset Analysis from the GALAXY Study in CIRCULATE-Japan
2024 · Clinical Cancer Research · 14 citations
https://doi.org/10.1158/1078-0432.ccr-24-2396
Evaluating genome architecture of a complex region via generalized bipartite matching
2013 · BMC Bioinformatics · 8 citations
https://doi.org/10.1186/1471-2105-14-s5-s13
Metadata record for the manuscript: Analytical validation of a targeted liquid biopsy assay with comprehensive molecular and clinical profiling of circulating tumor DNA from 1,000 patients
2021 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.14672673
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat